Resolve Biosciences
PrivateLast Round
Series B
Oct 24, 2022
Total Funding Raised
$95M
Company Overview
Resolve Biosciences operates in Healthcare & Life Sciences and is based in Monheim am Rhein. Its latest recorded funding round was a Series B round in October 2022.
Resolve Biosciences is a biotechnology company that provides a molecular cartography platform for high-resolution spatial analysis of tissue architecture and cellular function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resolve Biosciences Comparables
Compare Resolve Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vizgen | 87% | |
| Spatial Genomics | 86% | |
| Takara Holdings Inc. | 85% |
For institutional investors. Book with your work email.
Resolve Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 24, 2022 | ||||
| Series A | Dec 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resolve Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PS Capital Partners | Series A, Series B |
| Patient Square Capital | Series B |
| EDBI | Series B |
| MasterMind Transactions & Investment GmbH | Series A |
| NRW.Bank | Series B |
| High-Tech Gründerfonds | Series A |
| Alafi Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2022
$71M round led by Patient Square Capital and PS Capital Partners.
- Dec 10, 2020
$24M round led by MasterMind Transactions & Investment GmbH and PS Capital Partners.
For institutional investors. Book with your work email.
Resolve Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resolve Biosciences's valuation, stock price, and market status.
Is Resolve Biosciences a public or private company?
Resolve Biosciences is a private company.
What is the current stock price of Resolve Biosciences?
Resolve Biosciences is a private company, so its shares have no public market price. Caplight tracks Resolve Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resolve Biosciences worth (valuation)?
Valuation information for Resolve Biosciences is not publicly available.
Can I buy Resolve Biosciences stock?
Resolve Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resolve Biosciences's last funding round?
Resolve Biosciences's most recent funding round was Series B on October 24, 2022.
Who are the main investors in Resolve Biosciences?
Key investors in Resolve Biosciences include PS Capital Partners, Patient Square Capital, MasterMind Transactions & Investment GmbH.
Will Resolve Biosciences IPO soon?
No public IPO plans have been announced for Resolve Biosciences.
How can I track Resolve Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Resolve Biosciences's shares on secondary markets.